Canada markets closed

  • S&P/TSX
    17,909.03
    -49.07(-0.27%)

  • S&P 500
    3,768.25
    -27.29(-0.72%)

  • DOW
    30,814.26
    -177.24(-0.57%)

Solid Biosciences Inc. (SLDB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
6.48+0.02 (+0.31%)
At close: 4:00PM EST
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2019-12-31
2018-12-31
2017-12-31
Total Revenue
0
0
0
0
Operating Expenses
Research Development
94,737
94,737
57,965
39,905
Selling General and Administrative
24,581
24,581
17,722
14,952
Total Operating Expenses
119,318
119,318
75,687
54,857
Operating Income or Loss
-119,318
-119,318
-75,687
-54,857
Total Other Income/Expenses Net
515
515
270
1,460
Income Before Tax
-117,223
-117,223
-74,798
-53,178
Income from Continuing Operations
-117,223
-117,223
-74,798
-53,178
Net Income
-117,223
-117,223
-74,798
-52,118
Net Income available to common shareholders
-117,223
-117,223
-74,798
-39,317
Basic EPS
-
-2.91
-2.25
-1.22
Diluted EPS
-
-2.91
-2.25
-1.22
Basic Average Shares
-
40,289
33,263
32,229
Diluted Average Shares
-
40,289
33,263
32,229
EBITDA
-
-116,494
-74,121
-54,409